Methyl quinoline-2-carboxylate
CAS No. 19575-07-6
Methyl quinoline-2-carboxylate( —— )
Catalog No. M37047 CAS No. 19575-07-6
Methyl quinoline-2-carboxylate (Methyl 2-quinolinecarboxylate) inhibits the binding of Mycobacterium tuberculosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameMethyl quinoline-2-carboxylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl quinoline-2-carboxylate (Methyl 2-quinolinecarboxylate) inhibits the binding of Mycobacterium tuberculosis.
-
DescriptionMethyl quinoline-2-carboxylate (Methyl 2-quinolinecarboxylate) inhibits the binding of Mycobacterium tuberculosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19575-07-6
-
Formula Weight187.19
-
Molecular FormulaC11H9NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(=O)C1=NC2=CC=CC=C2C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pivmecillinam hydroc...
Pivmecillinam hydrochloride is an orally active prodrug of mecillinam an extended-spectrum penicillin antibioticand?is active against gram-negative organisms and used as for amdinocillin.
-
MsbA inhibitor 1
MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.
-
CRS-3123
A novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI).
Cart
sales@molnova.com